Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
@Hawkeiz Do your research. The filings mean they are desperate for cash to pay Nathanielsz and his pot selling partner's large salaries. If you read the financials and the filings, you'd see that this loan will most like get converted into shares and will ultimately dilute your holdings. You and Biochimp are clueless. This company is a SCAM!
All these filings are leading to something big IMO
They took out that bid 0.0012. Next up is 8M 0.0011.
And by the way, I've sent all of this information to the SEC and have asked them to investigate.
This 8K just added to the SEC's website....more bad debt/notes and more upcoming dilution. You penny stock addicted gamblers will never learn!
https://www.streetinsider.com/SEC+Filings/Form+8-K+Propanc+Biopharma%2C+Inc.+For%3A+Jun+26/23426670.html
Biochimp please tell me you're a college student...at least then you'd have an excuse for having such poor judgement. And BTW, Propanc's Medical Chief and Founder will soon have a criminal record.
https://www.dailymail.co.uk/news/article-13525605/Harley-Street-doctor-cancer-patient-cannabis-treatment.html
Keep posting, you are on ignore buddy.
Ace69 and Biochimp are both going to be screwed if Propanc decides to do another reverse split--just as they've done the previous 4X in the past 6 years! You guys will never learn!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1517681/000149315224025929/form8-k.htm
New 8K. More notes and upcoming dilution. If Propanc does a RS, you will be screwed!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1517681/000149315224025929/form8-k.htm
No need to look much further. They just released a new 8K. More notes and upcoming dilution. You guys will never learn!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1517681/000149315224025929/form8-k.htm
Looking for a sign its ready to add
Looks like the selling has really slowed down or stopped that's good news ready for the next step. IMO
Just waiting for the next PR this could get exciting
lol - we get it - You are a basher...jesus
Go. PPCB. Skies the limit here.
Go PPCB. Past never has equal the future of any company… I meant that doesn’t know this is an idiot.M
LOL Biochimp..thats a good one.
Where did Biochimp and the other pumpers go? I guess they're off pumping and gambling on another worthless and fraudulent OTC penny stocks.
Just admit that you're low IQ and I was right all along about this turd!
If you still see potential in a company led by a man with a history of fraud and who has wiped out countless investors after his many reverse splits and dilution, then you have the cognitive ability of Biden!
I’m not longer in here, still see potential here and will keep watching. Sure there are cons here but you don’t have to remind the board daily.
I'm wondering the same thing: Why is a Chief Medical Officer, founder, and co-board chairman of a publicly traded company spending his time selling weed cures instead of focusing on running his publicly traded biopharma company? Not to mention, the four reverse splits in the past six years, which is also troubling and historic. And BTW, all investors were wiped out after each of these splits--once the sell off by the note holders occurred.
Would like to see a .0015 close today.
Why wasn't Dr Kenyon pushing Propanc's product?? He was pushing light therapy and a cannabis product!!
Nice find btw!
This company has generated zero sales/revenue since its incorporation in 2007. Do you know how they have survived since then? And do you know when they will generate sales?
Can you explain the reason for 3 reverse splits in the past 5 years?
Is the man in the article the founder and Chief Medical Officer at Propanc Biopharma? Yes or No? Is he being accused of fraud? Yes or No?
https://www.dailymail.co.uk/news/article-13525605/Harley-Street-doctor-cancer-patient-cannabis-treatment.html
I would think you have to have a low IQ to constantly post on a board that doesn't care what you type and a stock you don't like
You're calling me low IQ when I've provided data and facts? What have you provided this forum?
This is why only low IQ people live in echo chambers and are ideologues!
Is the man in the article published June 13, 2024 the Chief Medical Officer and Founder of Propanc Biopharma? Also, I'm assuming you're a new bag holder onboard since last May 2023's reverse split--otherwise, you would have been wiped out like those bag holders from the previous 4 splits in the last 6 years!
Here's your company's founder and chief medical officer!
https://www.dailymail.co.uk/news/article-13525605/Harley-Street-doctor-cancer-patient-cannabis-treatment.html
Good morning low IQ pumpers. Quick question: Did you know that Propanc's founder, board of directors member, and chief medical officer is a medical fraud?
https://www.dailymail.co.uk/news/article-13525605/Harley-Street-doctor-cancer-patient-cannabis-treatment.html
You're clueless...the reverse split will raise the PPS, but not the value of your position. However, after the split and the sell off from the note holders, the price will fall back down to extremely low levels as it did in the past, thereby destroying your cost basis and making your stocks pretty much worthless. Just talk to those people who were around after the split! Oh' I forget, there are only new bag holders here now until the next split wipes them out.
Maybe in two to three years after running to $0.01 - $0.05? Only god knows.
Don't listen to pumpers like BIOCHEMUP and others. This stock has had three reverse splits in the past five years, so these guys are all new pumpers to the dead party as the last pumpers were all wiped out last year after the last split in May 2023. After these guys you're talking to are wiped out after the next split, there will be new bag holders boarding for the next round! And by the way, because these guys on this forum are so low IQ, I'm sure they don't know how to figure out when the next split will come...aka the day they get wiped out!
May 23, 2023, 1:1000
Nov 19, 2020, 1:1000
Jun 24, 2019, 1: 500
Apr 20, 2017, 1: 250
This stock has had 3 reverse splits in the past 5 years, so I'm guessing that no one here now has been holding since May 23, 2023, or else you would be wiped out. So everyone here now are new bag holders until you're wiped out in the next split after the massive dilution is complete. Then after you're wiped out and gone, there will be a new group of bag holders. And by the way, because these guys are so low IQ, I'm sure they can't even figure out when the next reverse split will occur--aka...the day they see their investments vanish!
May 23, 2023, 1: 1000
Nov 19, 2020, 1:1000
Jun 24, 2019, 1: 500
Apr 20, 2017, 1: 250
This will have its day again, just some patience needed.
U see ppcb .0014 yesterday and nnax .0011.....now nnax .0023....
Nah, you aren't bad luck! These plays are really quick and few and far between (ones w/ real substantial runs)... IMO. Ive been late to quite a few of the "parties" myself. Maybe our luck is about to change.... maybe the rest of the year we will nail some big runners. Always great to catch up with you!!
Still thinking we get bigger and better news with this stock, PPCB.... we are moving in right direction.. fingers crossed we start holding these gains and continue move upward... sustained move upward.
Struc
This will rise.
They have the goods.
Float is still relatively small.
You gotta buy 0.0011 and sell 0.0015 rinse and repeat.
Followers
|
425
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
49023
|
Created
|
05/18/14
|
Type
|
Free
|
Moderators |
This section maintained by INV4
Offering New Hope to Cancer Patients and Their Caregivers
About Propanc Biopharma, Inc. The Company’s novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body’s primary defense against cancer. A Long-Term Therapy Based on a Pancreatic Proenzyme Formulation Developing Long-Term Therapy for the Treatment of Solid Tumors Technology Based on Pancreatic Proenzyme Therapy Treatments that Inhibit Tumor Growth and Metastasis Our Lead Product: PRP Technology Based on Pancreatic Enzyme Therapy More than one hundred years ago, Professor John Beard first proposed that the pancreatic enzymes represent the body’s primary defense against cancer and would be useful as a cancer treatment. Since then, several scientists have endorsed Beard´s hypothesis with encouraging data from patient treatment. |
Click here for the video (with sound)
====================== PPCB SECURITY DETAILS ======================
Share Structure
Market Cap | 1,652,679 | 02/27/2023
Authorized Shares | 10,000,000,000 | 02/13/2023
Outstanding Shares | 1,836,310,391 | 02/13/2023
Restricted | 194,354,827 | 02/13/2023
Unrestricted | 1,641,955,564 | 02/13/2023
Held at DTC | 1,641,916,456 | 02/13/2023
Board of Directors James Nathanielsz has served as a director and Chief Executive Officer of our company since October 2007. From July 2006 until October 2007, Mr. Nathanielsz served as the New Products Manager of Biota Holdings Limited, an anti-infective drug development company in Australia. Mr. Nathanielsz was selected as a director because he is the Co-Founder of Propanc and for his experience in R&D and manufacturing and distribution. Mr. Nathanielsz holds a B.App.Sci in Biochemistry/Applied Chemistry and an M.E.I. from Swinburne University of Technology in Melbourne, Australia. ============== Dr. Julian Kenyon founded our company and was appointed as a director on February 12, 2008. Since 2000, Dr. Kenyon has served as an integrated medical physician and Medical Director of the Dove Clinic for Integrated Medicine in Winchester and London. He was the Founder-Chairman of the British Medical Acupuncture Society in 1980 and Co-Founder of the Centre for the Study of Complementary Medicine in Southampton and London. Dr. Kenyon was selected as a director because he is the Co-Founder of the Australian subsidiary and the business is based on his initial work at the Dove Clinic. Dr. Kenyon holds an M.B.Ch.B. and M.D. from the University of Liverpool Since 1972, he was appointed a Primary Fellow of the Royal College of Surgeons, Edinburgh. ============== Mr Zelinger is a Certified Practicing Accountant with 45 years of experience in tax, auditing, finance, investment and management consulting. Mr Zelinger also has significant expertise in property management and import/export businesses. Mr Zelinger commenced his career as an accountant at L.M. Stanton & Partners - Chartered Accountants, subsequently joining Caston Pty Ltd in 1980, a steel manufacturer as Chief Financial Officer, and Company Director, until 1983. Since the mid-1980’s until current date, Mr Zelinger serves as Director in several private investment companies in a range of businesses including property portfolio manager of commercial real estate, import/export businesses and a range of commercial and financial investment companies. Since 1980, Mr Zelinger also operates as a sole practitioner in accountancy and tax consulting. In 1973, Mr Zelinger graduated in Accounting and admitted as a Fellow of RMIT University in Business. He has been a Certified Practicing Accountant since 1984. Mr. Zelinger is a shareholder of Propanc Biopharma Inc. since 2010. ======================================================================== Company Info Industry Classifications |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |